DE69434430D1 - Liposom mit oligosaccharid auf der oberfläche - Google Patents

Liposom mit oligosaccharid auf der oberfläche

Info

Publication number
DE69434430D1
DE69434430D1 DE69434430T DE69434430T DE69434430D1 DE 69434430 D1 DE69434430 D1 DE 69434430D1 DE 69434430 T DE69434430 T DE 69434430T DE 69434430 T DE69434430 T DE 69434430T DE 69434430 D1 DE69434430 D1 DE 69434430D1
Authority
DE
Germany
Prior art keywords
liposom
oligosaccharide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69434430T
Other languages
English (en)
Other versions
DE69434430T2 (de
Inventor
Masakazu Hatanaka
Tsuguo Mizuochi
Masanobu Sugimoto
Kazue Ohishi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Tokyo NUC
Original Assignee
Tonen General Sekiyu KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tonen General Sekiyu KK filed Critical Tonen General Sekiyu KK
Application granted granted Critical
Publication of DE69434430D1 publication Critical patent/DE69434430D1/de
Publication of DE69434430T2 publication Critical patent/DE69434430T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6905—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a colloid or an emulsion
    • A61K47/6911—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a colloid or an emulsion the form being a liposome
DE69434430T 1993-10-29 1994-10-28 Liposom mit oligosaccharid auf der oberfläche Expired - Lifetime DE69434430T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP1272693 1993-10-29
JP5272693A JP2828391B2 (ja) 1993-10-29 1993-10-29 オリゴ糖を表面に有するリポソーム
PCT/JP1994/001828 WO1995011704A1 (fr) 1993-10-29 1994-10-28 Liposome a oligosaccharide de surface

Publications (2)

Publication Number Publication Date
DE69434430D1 true DE69434430D1 (de) 2005-08-25
DE69434430T2 DE69434430T2 (de) 2006-05-24

Family

ID=17517485

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69434430T Expired - Lifetime DE69434430T2 (de) 1993-10-29 1994-10-28 Liposom mit oligosaccharid auf der oberfläche

Country Status (6)

Country Link
US (1) US5759572A (de)
EP (1) EP0677295B1 (de)
JP (1) JP2828391B2 (de)
CA (1) CA2152917C (de)
DE (1) DE69434430T2 (de)
WO (1) WO1995011704A1 (de)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CO4600681A1 (es) * 1996-02-24 1998-05-08 Boehringer Ingelheim Pharma Composicion farmaceutica para la modulacion inmunitaria
WO1998004272A1 (en) * 1996-07-25 1998-02-05 The University Of Washington Chlamydia oligosaccharides
US20020173483A1 (en) 1999-02-19 2002-11-21 Cho-Chou Kuo Chlamydia oligosaccharides
ES2129342B1 (es) * 1996-12-19 2000-03-16 Hipra Lab Sa "formulacion de vacunas liposomales y su preparacion".
US20060165606A1 (en) * 1997-09-29 2006-07-27 Nektar Therapeutics Pulmonary delivery particles comprising water insoluble or crystalline active agents
DE69940805D1 (de) 1998-01-31 2009-06-10 Sinai School Medicine Verfahren und reagenzien zur verminderung der klinischen reaktion zur allergie
US7879977B2 (en) 1998-01-31 2011-02-01 University Of Arkansas Methods and reagents for decreasing clinical reaction to allergy
US6593308B2 (en) * 1999-12-03 2003-07-15 The Regents Of The University Of California Targeted drug delivery with a hyaluronan ligand
US8246945B2 (en) * 2000-04-06 2012-08-21 University Of Arkansas Methods and reagents for decreasing clinical reaction to allergy
US20050063994A1 (en) * 2000-04-06 2005-03-24 Caplan Michael J. Methods and reagents for decreasing clinical reaction to allergy
CA2403292C (en) 2000-04-06 2011-02-08 Panacea Pharmaceuticals, Llc Microbial delivery system
US7871598B1 (en) 2000-05-10 2011-01-18 Novartis Ag Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
US8404217B2 (en) 2000-05-10 2013-03-26 Novartis Ag Formulation for pulmonary administration of antifungal agents, and associated methods of manufacture and use
AU6124601A (en) 2000-05-10 2001-11-20 Alliance Pharmaceutical Corporation Phospholipid-based powders for drug delivery
US20020106368A1 (en) * 2000-07-28 2002-08-08 Adrian Bot Novel methods and compositions to upregulate, redirect or limit immune responses to peptides, proteins and other bioactive compounds and vectors expressing the same
US7141236B2 (en) * 2000-07-28 2006-11-28 Nektar Therapeutics Methods and compositions for delivering macromolecules to or via the respiratory tract
CA2427467C (en) * 2000-11-09 2010-01-12 Neopharm, Inc. Sn-38 lipid complexes and methods of use
US7087212B2 (en) * 2001-08-17 2006-08-08 Mallinckrodt, Inc Multicomponent assemblies having enhanced binding properties for diagnosis and therapy
US7070801B2 (en) 2002-01-30 2006-07-04 National Institute Of Advanced Industrial Science And Technology Sugar-modified liposome and products comprising the liposome
EP1447081B1 (de) * 2002-01-30 2010-02-10 National Institute of Advanced Industrial Science and Technology Zucker-modifizierte Liposomen und diese Lipososomen enthaltende Produkte
US20040131631A1 (en) * 2002-11-22 2004-07-08 Alexander Andrianov Polyphosphazene immunostimulants
WO2005011632A1 (ja) * 2003-08-01 2005-02-10 National Institute Of Advanced Industrial Science And Technology 糖鎖を有する標的指向性および腸管吸収制御性リポソームならびにそれを含む癌治療薬および診断薬
WO2005087196A1 (ja) * 2004-03-17 2005-09-22 Tokai University Educational System 免疫応答システムを利用したドラッグデリバリーシステム
JPWO2005097155A1 (ja) * 2004-04-08 2008-02-28 タカラバイオ株式会社 神経突起伸長誘導剤
JPWO2006104199A1 (ja) * 2005-03-29 2008-09-11 学校法人東海大学 免疫誘導のためのリポソーム組成物
US7595372B2 (en) * 2005-04-07 2009-09-29 Momentive Performance Materials Inc. Epoxy silane oligomer and coating composition containing same
GB2430881B (en) * 2005-10-06 2010-10-13 Ntnu Technology Transfer As Oligoelectrolyte polyols for the treatment of mucosal hyperviscosity
JP2007308472A (ja) * 2006-04-20 2007-11-29 Toray Ind Inc オリゴ糖を表面に有するリポソームを含むアレルギー治療剤
AU2006342615B8 (en) * 2006-04-20 2012-07-05 Tokai University Educational System Therapeutic agent for allergy containing liposome having oligosaccharide on its surface
JP2010504970A (ja) * 2006-09-26 2010-02-18 アレクシオン ファーマシューティカルズ， インコーポレイテッド アジュバントを増強するための組成物および方法
GB0707096D0 (en) * 2007-04-12 2007-05-23 Ntnu Technology Transfer As Method
AU2009294106B2 (en) 2008-09-17 2014-07-10 Obihiro University Of Agriculture And Veterinary Medicine Vaccine preparation for Neospora caninum infection
GB0904942D0 (en) 2009-03-23 2009-05-06 Ntnu Technology Transfer As Composition
GB0904941D0 (en) * 2009-03-23 2009-05-06 Ntnu Technology Transfer As Composition
CN102448488B (zh) 2009-06-04 2014-10-15 独立行政法人产业技术综合研究所 支原体感染症用疫苗
EP2735314B1 (de) 2011-05-02 2018-10-17 BioMedCore Inc. Dragierte liposomenzusammensetzung
JP5866724B2 (ja) * 2011-05-06 2016-02-17 公立大学法人大阪府立大学 ｐＨ応答性リポソーム
WO2014034046A1 (ja) 2012-08-27 2014-03-06 国立大学法人帯広畜産大学 トキソプラズマ感染症に対するワクチン製剤
EP2918262B1 (de) 2014-03-10 2023-08-09 PLS-Design GmbH Induktion einer antigenspezifischen Toleranz durch periphere Phagozytose

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6045588A (ja) * 1983-08-23 1985-03-12 Rikagaku Kenkyusho 新規オリゴマンノシドおよびその製造法
FR2596651B1 (fr) * 1986-04-08 1989-11-10 Centre Nat Rech Scient Nouveaux liposomes a base de phosphatidylinositolmannosides, et compositions pharmaceutiques les contenant
JPH0689042B2 (ja) * 1986-12-23 1994-11-09 理化学研究所 スフィンゴ糖脂質関連化合物の製造法
PH26549A (en) * 1987-04-03 1992-08-19 Meito Sangyo Kk Mannobiose derivatives
JP2653460B2 (ja) * 1987-04-03 1997-09-17 第一製薬株式会社 脂質膜構造体
WO1989008499A1 (en) * 1988-03-17 1989-09-21 Nippon Fine Chemical Co., Ltd. Liposome
US5332575A (en) * 1991-10-03 1994-07-26 Parfums Christian Dior Method of targeting melanocytes with a compound containing a fucose residue
WO1993017702A1 (en) * 1992-03-03 1993-09-16 Daiichi Pharmaceutical Co., Ltd. Oral vaccine

Also Published As

Publication number Publication date
EP0677295A1 (de) 1995-10-18
JP2828391B2 (ja) 1998-11-25
WO1995011704A1 (fr) 1995-05-04
CA2152917C (en) 2010-12-14
US5759572A (en) 1998-06-02
EP0677295B1 (de) 2005-07-20
JPH07126185A (ja) 1995-05-16
DE69434430T2 (de) 2006-05-24
EP0677295A4 (de) 1998-11-11
CA2152917A1 (en) 1995-05-04

Similar Documents

Publication Publication Date Title
DE69434430D1 (de) Liposom mit oligosaccharid auf der oberfläche
FI935495A (fi) Näyttöjärjestely
DE58905459D1 (de) Kühlerstutzen mit Verschlussdeckel.
NO20022254D0 (no) Injeksjonsspröyte
DE69106909T2 (de) Elektronische Baugruppe auf mehreren Ebenen mit Kühlungsmitteln.
NO922577D0 (no) Elastomermateriale
FI912221A (fi) Vattenhaltiga konsthartsprodukter.
FI921244A (fi) Ohjaustangossa oleva käyttölaitesovitelma
NO178819C (no) Spröyteinnretning
DE69300525T2 (de) Verbesserungen in bezug auf Gewindeteile.
FI960941A0 (fi) Ympäristöä erittäin vähän haittaava sellutehdas
IT9067986A0 (it) Macchina per scrivere elettronica.
FI940488A (fi) Näyttölaitejärjestely
DE69324681T2 (de) Entproteinisierung mit azlacton-gekoppelten funktionsträgern
DE69101956T2 (de) Thioaminal-Stabilisatoren.
FI955890A0 (fi) Suutinjärjestely
DE69011368T2 (de) Mikromagnetometer mit flexiblem Balken.
KR920005209U (ko) 전면판넬의 액정표시장치
DE9310391U1 (de) Der aschenbecher fuer unterwegs
FI934402A0 (fi) Kiinnityselin
BR9300909A (pt) Conexao rapida com contato
BR7200462U (pt) Decalque com liquido em movimento
BR7301940U (pt) Rodízio com freio-trava
LT2559B (lt) Alkoholoksidazes imobilizacijos budas
KR940019980U (ko) 하단부에 매직테이프를 부착한 작업복하의

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: TOKAI UNIVERSITY, TOKIO/TOKYO, JP